October 23, 2019
Landmark Study Seeks Participants with VCFS-Related Psychosis to Help Create Biobank of Human Neural Tissue to Develop Innovative Treatments
A landmark study is calling for at least 50 people in the U.S. with Velo-Cardio-Facial Syndrome (VCFS)-related psychosis to provide blood samples to create the world’s largest VCFS biobank to date of tiny spheres of neural tissue called ‘cerebral organoids’. Given that current medications used to treat VCFS- related psychosis are largely ineffective, researchers hope to discover novel and effective treatments for this condition by studying these cerebral organoids.
More. . .
Pictured left to right: Sander Markx, M.D., Assistant Professor of Psychiatry at Columbia University Medical Center and Robert J. Shprintzen, Ph.D. President and Chairman of the Board at the Virtual Center for Velo-Cardio-Facial Syndrome